ARTICLE
18 May 2021

COVID-19 Key EU Developments, Policy & Regulatory Update No. 46

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.
European Union Coronavirus (COVID-19)
Kaarli H. Eichhorn’s articles from Jones Day are most popular:
  • with Inhouse Counsel
  • in Asia

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission receives Recovery and Resilience Plans from 14 Member States
  • EU approves new and amended Member State measures to support the economy

Trade / Export Controls

  • EU-Republic of Korea Trade Agreement enabled sustained trade despite pandemic
  • European Commission releases biennial Report on the Protection and Enforcement of Intellectual Property Rights (IPR) in Third Countries

Medicines and Medical Devices

  • European Medicines Agency starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated
  • European Medicines Agency commences assessment of Pfizer//BioNTech COVID-19 vaccine for younger population
  • European Commission launches public consultation on the European Health Data Space

Cybersecurity, Privacy & Data Protection

  • No noteworthy developments for this issue

To view the full article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More